Central Garden (CENT) Buys Remaining Interest in FourStar Microbial
Tweet
Share
E-mailGet Alerts CENT Hot Sheet
Join SI Premium – FREE
Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading innovator, marketer and producer of quality branded products for the lawn and garden and pet supplies markets, announced today that it has purchased the remaining majority interest in New York based FourStar Microbial Products, LLC to complement its mosquito control business.
FourStar microbial products are derived from naturally-occurring soil bacteria and stop juvenile mosquitoes from emerging into flying and breeding adult flying insects that can bite and spread disease. The product’s residual lasts from 7 to 180 days and is formulated into granules and briquets for ease of application into various mosquito breeding sites. While the acquisition is not expected to have a material impact on the Company’s 2013 financial results, it will enhance its capability to service professional providers of mosquito abatement.
Nearly 2,000 mosquito control entities in the United States are charged with making decisions on the types of products used in their districts to reduce mosquito populations in an effort to protect the public and halt the spread of disease.
FourStar microbial products are derived from naturally-occurring soil bacteria and stop juvenile mosquitoes from emerging into flying and breeding adult flying insects that can bite and spread disease. The product’s residual lasts from 7 to 180 days and is formulated into granules and briquets for ease of application into various mosquito breeding sites. While the acquisition is not expected to have a material impact on the Company’s 2013 financial results, it will enhance its capability to service professional providers of mosquito abatement.
Nearly 2,000 mosquito control entities in the United States are charged with making decisions on the types of products used in their districts to reduce mosquito populations in an effort to protect the public and halt the spread of disease.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
- NAPCO Security Tech (NSSC) Tops Q4 EPS by 11c
- Raymond James cuts airline estimates on higher fuel, upgrades Allegiant
Create E-mail Alert Related Categories
Mergers and AcquisitionsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
